Valuation: FDC Limited

Market Cap 52.29B 543M 474M 439M 403M 762M 775M 5.23B 2.06B 25.54B 2.04B 1.99B 88.17B P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 47.15B 489M 428M 396M 363M 687M 699M 4.72B 1.85B 23.02B 1.84B 1.8B 79.48B EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.38%
1 week-2.82%
Current month-0.88%
1 month+10.32%
3 months+17.20%
6 months+7.95%
Current year-0.71%
1 week 413.55
Extreme 413.55
435
1 month 380.2
Extreme 380.2
442
Current year 312.95
Extreme 312.95
442
1 year 312.95
Extreme 312.95
527.8
3 years 312.95
Extreme 312.95
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 2009-11-18
Chief Executive Officer 63 1993-09-29
Director of Finance/CFO - 2025-10-23
Director TitleAgeSince
Director/Board Member 63 1993-09-29
Director/Board Member 48 2001-12-31
Director/Board Member 84 2009-11-15
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%-2.82% - - 713M
+1.08%-3.93%+48.03%+160.13% 1,043B
+1.19%-3.52%+51.70%+56.36% 602B
+4.21%+1.79%+33.48%+87.04% 449B
+1.15%-0.18%+30.74%+25.28% 327B
+1.38%+0.74%+34.13%+47.43% 279B
-0.36%-1.84%+22.17%+23.51% 264B
+3.70%+2.19%+24.27%+63.38% 201B
+3.49%+1.08%+24.08%+76.58% 169B
+1.29%+3.67%+2.15%-30.78% 143B
Average +0.98%-0.68%+30.08%+56.55% 386.34B
Weighted average by Cap. +1.00%-1.82%+37.65%+83.10%

Financials

2024 2025
Net sales 19.43B 202M 176M 163M 150M 283M 288M 1.94B 764M 9.49B 757M 741M 32.76B 21.08B 219M 191M 177M 162M 307M 312M 2.11B 829M 10.29B 822M 804M 35.54B
Net income 3.05B 31.68M 27.69M 25.61M 23.5M 44.47M 45.24M 305M 120M 1.49B 119M 116M 5.15B 2.67B 27.69M 24.2M 22.38M 20.54M 38.87M 39.55M 267M 105M 1.3B 104M 102M 4.5B
Net Debt -4.55B -47.21M -41.27M -38.16M -35.02M -66.28M -67.43M -455M -179M -2.22B -177M -173M -7.67B -5.15B -53.44M -46.71M -43.2M -39.64M -75.03M -76.33M -515M -202M -2.51B -201M -196M -8.68B
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
26-07-17 420.10 -0.38% 86,854
26-07-16 ₹421.70 -0.57% 127,975
26-07-15 ₹424.10 +0.58% 52,937
26-07-14 ₹421.65 -1.48% 81,286
26-07-13 ₹428.00 -0.99% 108,030
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B